Public consultation on measures for improving the recognition of prescriptions issued in another Member State
ILGA-Europe and Transgender Europe jointly submitted input for a public consultation on measures for improving the recognition of prescriptions issued in another European Union Member State. Download the joint submission and read the key concerns here.
Key concerns highlighted in our submission:
- We are worried by the fact that in some cases, trans persons were denied products on the basis that dispensers disapprove of their gender reassignment.
- It seems that some medicines, on which trans persons very much depend, are available only in some member states and not in other.
- We consider that the identification of the patient based solely on the first name or on the gender can be problematic in the case of patients whose appearance does not match the first name and the gender mentioned on the prescription.
- It seems that there is an extensive lack of knowledge within the trans community about the possibility of getting medicines prescribed in another member state.
If you have any question about this submission, then do not hesitate to contact Sophie Aujean, Policy and Programmes Officer.